![Alexzander Samuelsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexzander Samuelsson
Direktor/Vorstandsmitglied bei
HAVN LIFE SCIENCES INC.
Profil
Alexzander Samuelsson is the founder of Development Catalyst Strategy Corp., founded in 2016, holding the titles of President & Chief Science Officer.
Current jobs include Director at HAVN Life Sciences, Inc. since 2022 and Chief Science Officer at Melabis, Inc. since 2019.
Former job includes Director at Right Season Investments Corp.
from 2019 to 2020.
Education includes an undergraduate degree from Toronto Metropolitan University, conferred in 2014.
Aktive Positionen von Alexzander Samuelsson
| Unternehmen | Position | Beginn |
|---|---|---|
| HAVN LIFE SCIENCES INC. | Direktor/Vorstandsmitglied | 14.10.2022 |
Melabis, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2019 |
Development Catalyst Strategy Corp. | Gründer | 01.01.2016 |
Ehemalige bekannte Positionen von Alexzander Samuelsson
| Unternehmen | Position | Ende |
|---|---|---|
| FUTUREGEN INDUSTRIES CORP. | Direktor/Vorstandsmitglied | 20.04.2020 |
Ausbildung von Alexzander Samuelsson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Right Season Investments Corp.
 Right Season Investments Corp. MiscellaneousMiscellaneous Operates as an investment issuer focused on investing growth capital into private and public companies | Miscellaneous |
Toronto Metropolitan University of
 Toronto Metropolitan University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HAVN Life Sciences, Inc.
 HAVN Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company and manufactures therapeutics | Health Technology |
Melabis, Inc. | |
Development Catalyst Strategy Corp. |
